A Prospective Pathological Study to Refine Radiotherapy CTV Delineation for ESCC after Neoadjuvant Chemoimmunotherapy
International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · e126-e127
DOI: 10.1016/j.ijrobp.2026.06.933 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von H. Yin und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Yin, H., Liang, G., Yang, J., Wang, Y., Zhou, Y., Ma, J., & Wang, X. (2026). A Prospective Pathological Study to Refine Radiotherapy CTV Delineation for ESCC after Neoadjuvant Chemoimmunotherapy. International Journal of Radiation Oncology*Biology*Physics, 126(1), e126-e127. https://doi.org/10.1016/j.ijrobp.2026.06.933
Vancouver
Yin H, Liang G, Yang J, Wang Y, Zhou Y, Ma J, et al. A Prospective Pathological Study to Refine Radiotherapy CTV Delineation for ESCC after Neoadjuvant Chemoimmunotherapy. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):e126-e127. doi:10.1016/j.ijrobp.2026.06.933
BibTeX
@article{Yin2026,
author = {Yin, H. and Liang, G. and Yang, J. and Wang, Y. and Zhou, Y. and Ma, J. and Wang, X.},
title = {A Prospective Pathological Study to Refine Radiotherapy CTV Delineation for ESCC after Neoadjuvant Chemoimmunotherapy},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {126},
number = {1},
pages = {e126--e127},
doi = {10.1016/j.ijrobp.2026.06.933}
}
EUVIMED